News Sentiment

LSTA sentiment intelligence

Lisata Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.27 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

72/100 classification confidence.

Company focus 37

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.8% over one week, -8.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Lisata Therapeutics (LSTA) holders see Kuva offer extended as over 5.1M shares tendered

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 72/100 classification
One-week reaction -1.8% Price digesting
Trend fit Trend inactive -8.1% over four weeks
Fair value 13.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 31
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 37
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Market source 6
TradingView 6
TradingKey 5
GlobeNewswire 4
Finviz 2
simplywall.st 2
dars.gov.et 1

Event Lens

What the news is about

Classified themes
Earnings 15
Deals and strategy 15
Market update 13
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45